Optic ischaemic neuropathy

1. Semaglutide is associated with optic ischaemic neuropathy in humans.

   “Notably, high disproportionality signals were detected for weight loss poor and optic ischaemic neuropathy.”

   HumansAdverse event reports listing semaglutide as the primary suspected drug

   Characterizing the Adverse Event Profile of Semaglutide: A Comprehensive U.S. Food and Drug Administration Adverse Event Reporting System-Based Pharmacovigilance Study

   Clinical nutrition ESPEN·12 Oct 2026

More on Semaglutide